drugset / Trial / NCT00005764

A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients

NCT00005764 ↗

Phase 4 Completed 100 enrolled Glaxo Wellcome
Treatment

Summary

The purpose of this study is to see if the findings of increased lactic acid and abnormal fat distribution get better when d4T is replaced with abacavir, abacavir plus lamivudine, or Combivir (a pill containing lamivudine plus zidovudine) in HIV-positive patients taking anti-HIV therapy including stavudine (d4T).

Timeline

Start
2000-05
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Abacavir Other / unclassified — —
Subject Lamivudine Other / unclassified — —
Subject Zidovudine Small molecule — —